Charity has urged the UK government to provide clarity on whether people receiving antibiotics can receive a COVID-19 vaccination
News
Entries now open for the Patient Partnership Index 2021
The Patient Partnership Index 2021 provides a unique opportunity for UK and global pharmaceutical companies to showcase, benchmark and measure the quality and impact of their advocacy with patient groups
The Stroke Association to fund study investigating strokes caused by COVID-19
The research forms part of the CVD-COVID-UK flagship project consortium
SMC approves funding for four new medicines on the NHS
BMS’ MS therapy Zeposia and AbbVie’s JAK inhibitor Rinvoq among latest approvals
AZ’s Imfinzi fails to improve overall survival in head and neck cancer again
Immunotherapy has previously failed in this therapy area
Jazz Pharmaceuticals to acquire GW Pharma for $7.2bn
Jazz will add GW’s plant-derived cannabinoid treatment Epidiolex to its roster
ONS reveals COVID-19’s impact on mental health in latest survey findings
The survey revealed that anxiety scores were at the highest levels since April 2020
Push Doctor partners with Well Pharmacy on UK’s first ‘pharmacy-first’ digital service
Over 50,000 patients will have direct access to local community pharmacists
UCB’s bimekizumab data in plaque psoriasis published in The Lancet
Phase III BE VIVID and BE READY studies both met their co-primary endpoints
Keytruda recommended for routine NHS use in lung cancer
Immunotherapy recommended for patients with or without PD-L1 tumour expression
Multiple rolling reviews kick-off for Novavax’s COVID-19 vaccine
Jab recently demonstrated 89.3% efficacy in UK trial
NICE launches public consultation for process review
Proposals include changes to NICE’s Highly Specialised Technologies programme
AstraZeneca and UCL to collaborate on two immuno-oncology projects
Projects will investigate immune checkpoints and contribute to the development of new cancer treatments
Exonate launches diabetic macular oedema trial
Study of lead asset is part of a collaboration with Janssen Pharmaceuticals
UK trial will evaluate safety of mixing different COVID-19 vaccines
Com-Cov study will be the first in the world to evaluate using different vaccines in a two-dose regimen
